New Harbor Capital Launches New ENT Platform; Waypoint Capital Acquires Allergy Partners

The fourth quarter of 2021 delivered six reported ENT practice acquisition, marking the highest ENT acquisition quarter we have seen to date.

After a Quiet Quarter for ENT & Allergy Practice Acquisitions, We See Increasing Opportunity in Q4

The third quarter of 2021 delivered one major reported ENT practice acquisition, still far below the peak of activity in Q1. In September, an investment from The Beekman Group formed a partnership with Allergy & ENT Associates, a management services organization that supports a network of sixteen ENT clinics in the Greater Houston area.

Quiet Quarter for ENT & Allergy Practices Acquisitions. Expect Increasing Opportunity for Large Practice Sellers

Although we did not track any reported transactions in Q2, the first half of 2021 delivered three reported ENT practice acquisitions.

Private Equity Interest in ENT & Allergy Practices Accelerates. Expect Increasing Opportunity for Large Practice Sellers.

The first quarter of 2021 delivered five reported ENT practice acquisitions marking the most active three-month M&A period we have seen in the specialty. Notably, Audax Private Equity formally named its portfolio company “Elevate ENT” and expanded into Texas with the major acquisition of Texas ENT Specialists. While the next quarter may not produce as many deals, activity should remain high throughout this year.